443087004: Saxagliptin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with hydrolase inhibitor mechanism of action (substance)\Peptide hydrolase inhibitor\Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)\Saxagliptin (substance)

\Drug or medicament (substance)\Saxagliptin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Nitrile\Saxagliptin (substance)

\Organic compound\Organic nitrogen compound\Nitrile\Saxagliptin (substance)
\Organic compound\Substance with alcohol structure (substance)\Saxagliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2010. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Saxagliptin (substance)	Is a	Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Is a	Oral hypoglycemic	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Has disposition	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Is a	Substance with alcohol structure (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Is a	Nitrile	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin (substance)	Is a	Drug or medicament (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Metformin hydrochloride + saxagliptin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Saxagliptin hydrochloride (substance)	Is a	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Saxagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Saxagliptin hydrochloride (substance)	Is modification of (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Saxagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing metformin and saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Metformin- and saxagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Metformin and saxagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Metformin and saxagliptin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin- and metformin- and saxagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin and metformin and saxagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely metformin hydrochloride 850 milligram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only dapagliflozin and saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing dapagliflozin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin and saxagliptin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dapagliflozin- and saxagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saxagliptin (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2834307019	Saxagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2840308015	Saxagliptin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2834307019	Saxagliptin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2834307019	Saxagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2840308015	Saxagliptin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2840308015	Saxagliptin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
52581000195112	saxagliptin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
66961000195119	Saxagliptin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
839471000172111	saxagliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
839471000172111	saxagliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
52581000195112	saxagliptin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
66961000195119	Saxagliptin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module